Peper; Janet

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peper; Janet.The latest application filed is for "novel fusion protein specific for cd137 and pd-l1".

Company Profile

25.20.26

Peper; Janet - Tuebingen DE
Peper; Janet - Freising DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 11,345,737 - Schuster , et al. May 31, 2	2022-05-31
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 11,278,571 - Schuster , et al. March 22, 2	2022-03-22
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 11,246,889 - Schuster , et al. February 15, 2	2022-02-15
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 11,248,035 - Schuster , et al. February 15, 2	2022-02-15
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 11,214,608 - Schuster , et al. January 4, 2	2022-01-04
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210363221 - SCHUSTER; Heiko ; et al.	2021-11-25
Novel Fusion Protein Specific For Cd137 And Pd-l1 App 20210363257 - Pavlidou; Marina ; et al.	2021-11-25
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210340216 - SCHUSTER; Heiko ; et al.	2021-11-04
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210340217 - SCHUSTER; Heiko ; et al.	2021-11-04
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210260122 - SCHUSTER; Heiko ; et al.	2021-08-26
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210260123 - SCHUSTER; Heiko ; et al.	2021-08-26
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210252066 - SCHUSTER; Heiko ; et al.	2021-08-19
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210252065 - SCHUSTER; Heiko ; et al.	2021-08-19
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210252064 - SCHUSTER; Heiko ; et al.	2021-08-19
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 11,078,253 - Schuster , et al. August 3, 2	2021-08-03
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 11,071,756 - Schuster , et al. July 27, 2	2021-07-27
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 11,053,296 - Schuster , et al. July 6, 2	2021-07-06
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210106624 - SCHUSTER; Heiko ; et al.	2021-04-15
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20210106623 - SCHUSTER; Heiko ; et al.	2021-04-15
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210101958 - SCHUSTER; Heiko ; et al.	2021-04-08
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210101957 - SCHUSTER; Heiko ; et al.	2021-04-08
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 10,899,820 - Schuster , et al. January 26, 2	2021-01-26
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20210009654 - SCHUSTER; Heiko ; et al.	2021-01-14
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,888,587 - Schuster , et al. January 12, 2	2021-01-12
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,881,690 - Schuster , et al. January 5, 2	2021-01-05
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,869,897 - Schuster , et al. December 22, 2	2020-12-22
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20200317748 - SCHUSTER; Heiko ; et al.	2020-10-08
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200316126 - SCHUSTER; Heiko ; et al.	2020-10-08
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200316127 - SCHUSTER; Heiko ; et al.	2020-10-08
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200316125 - Schuster; Heiko ; et al.	2020-10-08
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 10,781,244 - Schuster , et al. Sept	2020-09-22
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Grant 10,738,100 - Schuster , et al. A	2020-08-11
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,722,538 - Schuster , et al.	2020-07-28
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Ovarian Cancer And Other Cancers App 20200207832 - Schuster; Heiko ; et al.	2020-07-02
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200155603 - SCHUSTER; Heiko ; et al.	2020-05-21
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,639,332 - Schuster , et al.	2020-05-05
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,639,331 - Schuster , et al.	2020-05-05
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,568,909 - Schuster , et al. Feb	2020-02-25
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200000849 - SCHUSTER; Heiko ; et al.	2020-01-02
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20200000850 - SCHUSTER; Heiko ; et al.	2020-01-02
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20190381103 - SCHUSTER; Heiko ; et al.	2019-12-19
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 10,463,696 - Schuster , et al. No	2019-11-05
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers App 20180222961 - Schuster; Heiko ; et al.	2018-08-09
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20180117085 - SCHUSTER; Heiko ; et al.	2018-05-03
Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Grant 9,889,159 - Schuster , et al. February 13, 2	2018-02-13
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Epithelial Ovarian Cancer And Other Cancers App 20170035807 - SCHUSTER; Heiko ; et al.	2017-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.